Evaluation Safety, Tolerability, and Pharmacokinetics of Single and Multiple Ascending Doses of 83-0060 in Healthy Volunteers

PHASE1RecruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

April 15, 2024

Primary Completion Date

August 9, 2024

Study Completion Date

December 31, 2024

Conditions

Healthy Volunteers Only

Interventions

DRUG

83-0060

Oral MPro inhibitor

DRUG

Placebo

Trial Locations (1)

RECRUITING

Scientia Clinical Research, Sydney

All Listed Sponsors

collaborator

Trawsfynydd Therapeutics AU Pty Ltd

UNKNOWN

lead

Traws Pharma, Inc.

INDUSTRY